AF
Ami Fadia Needham Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $202 |
58%
upside
| Buy | 7 days ago |
|
2
Revolution Medicines
RVMD
$7.28B
| $38.95 | $56 |
44%
upside
| Buy | 28 days ago |
|
3
Merus
MRUS
$5.01B
| $66.23 | $96 |
45%
upside
| Buy | 29 days ago |
|
4
Day One Biopharmaceuticals
DAWN
$759M
| $7.41 | $16 |
116%
upside
| Buy | 29 days ago |
|
5
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $150 |
21%
upside
| Buy | 1 month ago |
|
6
Alkermes
ALKS
$4.77B
| $28.92 | $45 |
56%
upside
| Buy | 1 month ago |
|
7
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $30 |
18%
upside
| Buy | 2 months ago |
|
8
Praxis Precision Medicines
PRAX
$970M
| $46.09 | $80 |
74%
upside
| Buy | 2 months ago |
|
|
CNTA
9
Centessa Pharmaceuticals
CNTA
$2.12B
| $15.79 | $35 |
122%
upside
| Buy | 3 months ago |
|
10
Neumora Therapeutics
NMRA
$264M
| $1.63 | $5 |
207%
upside
| Buy | 3 months ago |
|
|
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $19 |
27%
upside
| Buy | 3 months ago |
|
12
Harmony Biosciences
HRMY
$2.09B
| $36.30 | $49 |
35%
upside
| Buy | 4 months ago |
|
13
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $139 |
1%
downside
| Buy | 4 months ago |
|
|
BCYC
14
Bicycle Therapeutics
BCYC
$483M
| $6.97 | $29 |
316%
upside
| Buy | 4 months ago |
|
|
15
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $210 |
64%
upside
| Outperform | 4 years ago |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $15.03 | $320 |
2,029%
upside
| Outperform | 4 years ago |
|
17
Pacira BioSciences
PCRX
$1.2B
| $26.73 | $75 |
181%
upside
| Market Perform | 4 years ago |
|
18
Perrigo
PRGO
$3.2B
| $23.29 | $63 |
171%
upside
| Outperform | 5 years ago |
|
|
AVDL
19
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $17 |
13%
upside
| Outperform | 5 years ago |
|